Hôpital Necker-Enfants Malades, Université Paris Descartes, 75743 Paris, France.
Nucleic Acids Res. 2011 Sep 1;39(17):7610-9. doi: 10.1093/nar/gkr524. Epub 2011 Jun 28.
Gene targeting can be achieved with lentiviral vectors delivering donor sequences along with a nuclease that creates a locus-specific double-strand break (DSB). Therapeutic applications of this system would require an appropriate control of the amount of endonuclease delivered to the target cells, and potentially toxic sustained expression must be avoided. Here, we show that the nuclease can be transferred into cells as a protein associated with a lentiviral vector particle. I-SceI, a prototypic meganuclease from yeast, was incorporated into the virions as a fusion with Vpr, an HIV accessory protein. Integration-deficient lentiviral vectors containing the donor sequences and the I-SceI fusion protein were tested in reporter cells in which targeting events were scored by the repair of a puromycin resistance gene. Molecular analysis of the targeted locus indicated a 2-fold higher frequency of the expected recombination event when the nuclease was delivered as a protein rather than encoded by a separate vector. In both systems, a proportion of clones displayed multiple integrated copies of the donor sequences, either as tandems at the targeted locus or at unrelated loci. These integration patterns were dependent upon the mode of meganuclease delivery, suggesting distinct recombination processes.
基因靶向可以通过携带供体序列的慢病毒载体和一种能够在特定基因座产生双链断裂(DSB)的核酸酶来实现。该系统的治疗应用需要适当控制递送到靶细胞的内切核酸酶的量,并避免潜在的毒性持续表达。在这里,我们表明,核酸酶可以作为与慢病毒载体颗粒相关联的蛋白质转移到细胞中。I-SceI 是一种来自酵母的典型巨核酸酶,与 HIV 辅助蛋白 Vpr 融合后被整合到病毒粒子中。在报告细胞中测试了含有供体序列和 I-SceI 融合蛋白的整合缺陷型慢病毒载体,通过修复嘌呤霉素抗性基因来对靶向事件进行评分。对靶向基因座的分子分析表明,当核酸酶作为蛋白质而不是由单独的载体编码时,预期的重组事件的频率提高了 2 倍。在这两种系统中,一部分克隆显示出供体序列的多个整合拷贝,要么是在靶向基因座上串联,要么是在不相关的基因座上。这些整合模式依赖于巨核酸酶的传递方式,表明存在不同的重组过程。